Abstract:Background: Cirrhosis leads to portal hypertension (PHT), affecting survival with limited treatment options. This study investigated Imperatorin (IMP), a furanocoumarin with anti-inflammatory and hypotensive properties, for its therapeutic role and mechanisms in cirrhotic PHT. Methods: Hepatic stellate cells (HSCs) inhibition by IMP was evaluated using LX-2 cell line. Rat cirrhosis was induced via CCl4 for 16 weeks. Experimental group were orally administered IMP (15/25 mg/kg/day) for 4 weeks. We subsequently examined portal pressure (PP), cirrhosis, inflammation, angiogenesis, and vascular remodeling. Network pharmacology was employed for mechanistic insights. Results: IMP significantly inhibited the fibrogenesis in HSCs and suppressed cell viability. CCl4 exposure induced cirrhosis, inflammation, angiogenesis, vascular remodeling and PHT. IMP significantly reduced PP from 22.85 ± 3.88 mmHg to 6.67 ± 0.6 mmHg, diminished collagen deposition and pro-fibrotic factor expression, alleviated inflammation, and improved liver function. Vessel wall thickness in superior mesenteric arteries was restored, and intra-/extrahepatic angiogenesis was inhibited via VEGF and vWF. Furthermore, IMP induced sinusoidal vasodilation by upregulating eNOS and GCH1. Enrichment analysis indicated that IMP was involved in various biological processes associated with cirrhosis, such as the regulation of blood pressure, tissue remodeling, response to inflammation, and regulation of angiogenesis, etc. Additionally, IMP suppressed hepatic expression of TGF-β both in vitro and in vivo, which was further supported by KEGG analysis. Conclusion: Our research demonstrated that IMP significantly mitigated cirrhosis PHT by reducing hepatic fibrosis and inflammation, curbing angiogenesis and vascular remodeling, and promoting vasodilation. This protective mechanism appears to be facilitated through the downregulation of TGF-β.

Imperatorin Alleviates ROS-mediated Airway Remodeling by Targeting the Nrf2/HO-1 Signaling Pathway

Effects of Imperatorin on Airway Remodeling in Bronchial Asthma Through S1PR2/STAT3 Signaling Pathway.

Imperatorin reduces airway inflammation in asthmatic mice through p38MAPK/NF-κB pathway

Imperatorin alleviated NLR family pyrin domain-containing 3 inflammasome cascade-induced synovial fibrosis and synovitis in rats with knee osteoarthritis

Imperatorin Interferes with LPS Binding to the TLR4 Co-Receptor and Activates the Nrf2 Antioxidative Pathway in RAW264.7 Murine Macrophage Cells

Imperatorin Ameliorates Mast Cell-Mediated Allergic Airway Inflammation by Inhibiting MRGPRX2 and CamKII/ERK Signaling Pathway.

Imperatorin ameliorates pulmonary fibrosis via GDF15 expression

Imperatorin Suppresses Anaphylactic Reaction and IgE-Mediated Allergic Responses by Inhibiting Multiple Steps of FceRI Signaling in Mast Cells: IMP Alleviates Allergic Responses in PCA

Imperatorin reduces the inflammatory response of atherosclerosis by regulating MAPKs signaling pathway <i>in vivo</i> and <i>in vitro</i>

IL-33 Promotes Airway Remodeling in a Mouse Model of Asthma Via ERK1/2 Signaling Pathway

Imperatorin prevents cardiac hypertrophy and the transition to heart failure via NO-dependent mechanisms in mice.

Preventive Effect of Imperatorin on Acute Lung Injury Induced by Lipopolysaccharide in Mice

Imperatorin Efficiently Blocks TNF-α-mediated Activation of ROS/PI3K/Akt/NF-κB Pathway.

Imperatorin Alleviates the Abnormal Proliferation, Migration, and Foaming of Ox-Ldl-induced VSMCs Through Regulating PI3K/Akt/mTOR Signaling Pathway

Effects of rosmarinic acid on the inflammatory response in allergic rhinitis rat models after PM2.5 exposure

Imperatorin attenuates CCl4-induced cirrhosis and portal hypertension by improving vascular remodeling and profibrogenic pathways

NOX4-Derived ROS Promotes Collagen I Deposition in Bronchial Smooth Muscle Cells by Activating Noncanonical p38MAPK/Akt-Mediated TGF-β Signaling

Peroxisome Proliferator Activated Receptor gamma (PPARγ) Agonist Rosiglitazone Ameliorate Airway Inflammation by Inhibiting Toll-Like Receptor 2 (TLR2)/Nod-Like Receptor with Pyrin Domain Containing 3 (NLRP3) Inflammatory Corpuscle Activation in Asthmatic Mice

Imperatorin Improves Obesity-Induced Cardiac Sympathetic Nerve Injury Mediated by P2X4 Receptor in Stellate Sympathetic Ganglion.

Effect of Puerarin in Inflammatory,Oxidative Stress,Remodeling of Airway on Chronic Obstructive Pulmonary Disease in Rats

Effects of liver X receptor in O3-induced airway inflammation and remodeling in mice